- Rating
- 2
- Confidence
- 3
- Informativeness
- 2
- Presentation
- 2
- Soundness
- 2
Read review
Paper summary
This paper proposes a UnPairRelNet framework for predicting multi-class DDI prediction. The model first constructs a relation graph based on relation types, generating relation representations through degree-based partial-order connection patterns and query-agnostic message passing. It then performs bidirectional propagation across the knowledge graph, using drug pairs as anchors; as this approach avoids entity-specific parameters, it can be generalized to new drugs. Finally, the model integrates multi-granularity molecular representations to make predictions. Experiments demonstrate that the model is highly effective.
Critical strengths
- Demonstrates strong generalization capabilities in the context of new drug development, with comprehensive experimental coverage.
- The analysis is detailed, with good transparency and reproducibility.
Critical weaknesses
- This paper is more akin to a combination of existing components; the knowledge graph (KG) module adopts the two-stage structure from ULTRA/NBFNet, and the ablation studies are insufficient to justify the attribution of contributions. Furthermore, while the paper’s primary innovation lies in the configuration for the S1/S2 drug discovery scenarios, it lacks ablation studies specifically for these settings. Consequently, it is impossible to determine whether the performance gains stem from the relational modeling or from the multimodal components.
- The paper lacks an analysis regarding interpretability. In the context of relational reasoning, it fails to demonstrate whether the learned relational representations capture meaningful relational structures. Models such as EmerGNN and KnownDDI, for instance, all provide path-level explanations.
Questions for authors
- The title emphasizes "relational reasoning". However, the relational module merely generates fixed relation vectors based on co-occurrence graphs. What exactly is meant by "relational reasoning" in this context? Could you provide examples of reasoning paths or combinations of relations to demonstrate that the model is indeed performing reasoning?
- The macro F1 score for the full model in the ablation table is 0.878, while it is 0.883 in the main table; what is the source of this discrepancy? Could you also report the standard deviation for each of the ablation variants?
- EmerGNN employs a flow-based propagation mechanism between drug pairs to predict novel DDIs, utilizing the same S1/S2 experimental settings. How does the M3 model proposed in this paper differ from EmerGNN? Furthermore, why is EmerGNN neither cited nor included as a baseline in this study?
- The final prediction concatenates representations from multiple branches and feeds them into an MLP. The ablation in Table 3 is conducted only in the transductive setting. Could the authors provide ablations under S1/S2 to clarify how much each branch (KG propagation, molecular encoders, descriptors) contributes to the gains on unseen drugs?